Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Source: SeekingAlpha
2026-04-20 11:55:48 ET
More on Health Care stocks
- IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
- Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
- Sector Rotation: Healthcare XLV Should Be The Next Stop
- Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
- Notable healthcare headlines for the week: J&J, Abbott and Organon in focus
Read the full article on Seeking Alpha
For further details see:
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Spyre Therapeutics Inc.
NASDAQ: SYRE
SYRE Trading
8.99% G/L:
$78.69 Last:
447,563 Volume:
$73.57 Open:
SYRE Latest News
SYRE Stock Data
$2,603,991,883
65,619,664
1.61%
44
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
